Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study.

Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. Abstract Text:

Yoshio Sumida,Kazuyuki Kanemasa,Kohei Fukumoto,Naohisa Yoshida,Kyoko Sakai,Toshiaki Nakashima,Takeshi Okanoue,

Increased hepatic iron deposition may play a role in the pathogenesis of nonalcoholic steatohepatitis (NASH). This study aimed to test whether iron removal by phlebotomy improves serum transaminase activities in patients with NASH. Eleven patients (six males and five females) with biopsy-proven NASH underwent phlebotomy biweekly until they reached near-iron deficiency (NID) (serum ferritin concentration lower than or equal to 30ng/ml). Nine patients completed this study. Serum ferritin levels in these patients fell from 563+/-322 to 18+/-9ng/ml (p=0.001). The treatment reduced mean serum alanine aminotransferase (ALT) activity from 126+/-47 to 56+/-17IU/l (p=0.002). Their weight did not change significantly throughout the study period. Although two patients withdrew from the study, none was affected by any side effects of repeated phlebotomy that required discontinuing the treatment. In conclusion, this pilot study suggests that iron reduction therapy by phlebotomy will be one of the promising therapies for NASH.

Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. Publishing Authors By Initials

Y Sumida,K Kanemasa,K Fukumoto,N Yoshida,K Sakai,T Nakashima,T Okanoue,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hepatology research : the official journal of the

VOLUME: 36

Page Numbers: 315-21

Journal Abbreviation: Hepatol. Res.

ISSN: 1386-6346

DAY: 12

MONTH: 09

YEAR: 2006

Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9711801

Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study.

AFFILIATION: Department of Gastroenterology and Hepatology, Nara City Hospital, Higashi-kidera cho 1-50-1, Nara 630-8305, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatol Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study Related Publications

• A case of adult-onset type II citrullinemia having a liver histology of nonalcoholic steatohepatitis (NASH).
• Activation of B-Myb by E2F1 in hepatocellular carcinoma.
• CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
• Clinicopathological characteristics of esophageal squamous papillomas in Japanese patients-with comparison of findings from Western countries.
• Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study.
• Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis.
• Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C.
• First phase viral kinetic parameters and prediction of response to interferon alpha-2b/ribavirin combination therapy in patients with chronic hepatitis C.
• Management of HBV infection in Japan.
• Molecular mechanisms involved in interleukin-8 production by normal human oesophageal epithelial cells.
• Preface.
• Review article: anti-tryptase therapy in inflammatory bowel disease.
• The severity of ultrasonographic findings in nonalcoholic Fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.
• [Indication of antiviral therapy for chronic hepatitis B]